Pharmaceutical Supply – Vecuronium Bromide (Active Pharmaceutical Ingredient)

The contract pertains to the supply of Vecuronium Bromide, an active pharmaceutical ingredient used as a neuromuscular blocking agent, to be delivered in compliant packaging and precise quantities suitable for integration into the U.S. government’s medical supply chain. The requirement is issued under a subcontract mechanism by the Department of Defense through its Medical Supply Chain Pharm FSA, with the NAICS code 325412 indicating classification under Pharmaceutical Preparation Manufacturing. All deliveries must meet federal standards for pharmaceutical integrity, labeling, and storage conditions to ensure compatibility with existing military and civilian medical logistics systems. The solicitation was posted on May 12, 2026, with responses due by May 15, 2026, indicating a tight turnaround window for qualified vendors to submit proposals. The place of performance and delivery specifications are not explicitly defined, suggesting flexibility in logistics as long as regulatory and supply chain integration criteria are satisfied. Vendors must demonstrate capacity to consistently provide high-purity API in adherence to current Good Manufacturing Practices and government procurement protocols.